Table 1 The Demographic data of glaucoma patients
Variable | N = 44 | |
|---|---|---|
Gender (male/female) | 22 eyes/ 22 eyes | |
Eye (Right/Left) | 32 eyes/ 37 eyes | |
Age [years] | 59.4 ± 11.8 (35 ~ 78) | |
Type of Glaucoma (POAG/NTG) | 17eyes/ 52eyes | |
Corrected Visual acuity (Log MAR) | −0.13 ± 0.06(− 0.18 ~ 0.00) | |
Spherical Equivalent [Diopters] | −1.94 ± 2.35(− 5.88 ~ + 3.00) | |
Intraocular Pressure [mmHg] | 13.8 ± 2.8(7 ~ 21) | |
Medication (With/Without) | 32/37 | |
mfPhNR/B | Center | 0.32 ± 0.10 (0.14 ~ 0.65) |
Superotemporal | 0.21 ± 0.09 (0.07 ~ 0.69) | |
Superonasal | 0.21 ± 0.06 (0.10 ~ 0.41) | |
Inferonasal | 0.25 ± 0.07 (0.12 ~ 0.42) | |
Inferotemporal | 0.25 ± 0.07 (0.12 ~ 0.47) | |
N/T | 0.83 ± 0.37 (0.11 ~ 2.50) | |
HFA Central 30–2 Program | ||
Mean Deviation [dB] (Early:> − 6/Moderate:-12≦ ≦ − 6/Advanced:<− 12) | −7.00 ± 7.34(− 29.92 ~ 2.06) 40/13/16 | |
Pattern Standard Deviation [dB] | 9.01 ± 5.23 (1.61 ~ 18.76) | |
Mean Threshold [dB] / Total Deviation | Center | 27.1 ± 7.0 (9.8 ~ 35.5) / -6.0 ± 6.8 (− 25.3 ~ 2.3) |
Superotemporal | 19.8 ± 8.8 (2.2 ~ 32.4) / -8.0 ± 9.2 (− 29.9 ~ 2.8) | |
Superonasal | 21.1 ± 11.6 (0.0 ~ 33.1) / -9.3 ± 12.1 (− 32.0 ~ 2.9) | |
Inferonasal | 22.6 ± 10.4 (0.0 ~ 33.4) / -8.7 ± 10.9 (− 33.1 ~ 2.8) | |
Inferotemporal | 23.8 ± 6.3 (0.0 ~ 30.6) / -4.3 ± 7.1 (− 32.6 ~ 2.0) | |
HFA Central 10–2 Program | ||
Mean Deviation [dB] | −6.31 ± 6.91(− 27.42 ~ 2.07) | |
Pattern Standard Deviation [dB] | 7.85 ± 5.66 (0.98 ~ 17.19) | |
Mean Threshold [dB]/Total Deviation | Superotemporal | 29.5 ± 7.4 (0 ~ 37.2) / -2.7 ± 6.1 (− 31.8 ~ 2.6) |
Superior | 22.9 ± 13.3 (0 ~ 36.8) / -10.0 ± 13.6 (− 35.5 ~ 3.0) | |
Superonasal | 25.1 ± 12.1 (0.2 ~ 36.8) / -9.5 ± 12.6 (− 35.6 ~ 3.2) | |
Inferonasal | 30.9 ± 6.8 (5.42 ~ 37.2) / -3.3 ± 7.0 (− 29.6 ~ 3.2) | |
Inferior | 31.1 ± 6.0 (6.5 ~ 36.5) / -2.1 ± 5.7 (− 28.3 ~ 2.0) | |
Inferotemporal | 32.5 ± 4.0 (10.2 ~ 36.2) / -0.4 ± 2.1 (− 7.0 ~ 3.0) | |
Circumpapillary retinal nerve fiber layer thickness [μm] | 69.8 ± 12.3(46 ~ 100) | |
OCT GCIPL thickness [μm]/ mRNFL thickness [μm]/ GCC thickness [μm] | Average | 68.9 ± 8.1(47 ~ 84)/ 26.7 ± 5.2(12 ~ 40)/ 95.6 ± 12.7(62 ~ 121) |
Superotemporal | 71.2 ± 10.4(38 ~ 90)/ 32.7 ± 8.6(10 ~ 47)/ 103.9 ± 17.4(60 ~ 132) | |
Superior | 64.6 ± 10.5(46 ~ 87)/ 25.6 ± 10.5(10 ~ 45)/ 90.2 ± 20.3(60 ~ 127) | |
Superonasal | 63.1 ± 11.5(46 ~ 87)/ 16.9 ± 6.1 (7 ~ 28)/ 80.0 ± 17.0(57 ~ 112) | |
Inferonasal | 68.4 ± 9.4(49 ~ 88)/ 18.7 ± 4.7 (7 ~ 29)/ 87.1 ± 13.4(58 ~ 112) | |
Inferior | 70.9 ± 10.3(33 ~ 88)/ 31.1 ± 6.4(14 ~ 46)/ 101.9 ± 15.8(55 ~ 134) | |
Inferotemporal | 75.2 ± 10.1(38 ~ 91)/ 35.0 ± 6.0(17 ~ 52)/ 110.1 ± 14.8(67 ~ 135) | |